Zweitmalignome nach therapie des morbus hodgkin: Das freiburger kollektiv 1940 bis 1991Second malignancies following treatment of Hodgkin’s disease: The freiburg patients 1940 to 1991

[11] Cellai E(1990)Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas Cancer 66 80-8

[12] Magrini SM(1996)Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin’s disease: Long-term analysis of risk factors and outcome Blood 87 3625-32

[13] Glanzmann C(1974)Analysis of relative survival and proportional mortality Comput Biomed Res 7 325-32

[14] Lütolf UM(1967)Die Frage der Heilbarkeit der Lymphogranulomatose, beurteilt nach den Behandlungsergebnissen der Freiburger Medizinischen Klinik Verh Dtsch Ges Inn Med 73 322-9

[15] Glanzmann C(1995)Breast cancer following treatment for Hodgkin’s disease: The need for screening in a young population Australasian Radiol 39 271-6

[16] Veraguth A(1986)Hodgkin’s disease: Is there a price for successful treatment? A 25-year experience J Clin Oncol 12 153-66

[17] Lütolf M(1977)Longterm side effects in irradiated patients with Hodgkin’s disease Int J Radiat Oncol Biol Phys 2 1-19

[18] Hellbardt A(1992)Risk of second primary cancers after Hodgkins’s disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation Br Med I 304 1137-43

[19] Mirimanoff RO(1997)Second malignancy in patients with Hodgkin’s disease treated at the Royal Marsden Hospital Br J Can 75 116-23

[20] Obradovic M(1984)Second malignant neoplasms complicating Hodgkin’s disease: The National Cancer Institute experience J Clin Oncol 2 762-9

[11] Cellai E(1990)Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas Cancer 66 80-8

[12] Magrini SM(1996)Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin’s disease: Long-term analysis of risk factors and outcome Blood 87 3625-32

[13] Glanzmann C(1974)Analysis of relative survival and proportional mortality Comput Biomed Res 7 325-32

[14] Lütolf UM(1967)Die Frage der Heilbarkeit der Lymphogranulomatose, beurteilt nach den Behandlungsergebnissen der Freiburger Medizinischen Klinik Verh Dtsch Ges Inn Med 73 322-9

[15] Glanzmann C(1995)Breast cancer following treatment for Hodgkin’s disease: The need for screening in a young population Australasian Radiol 39 271-6

[16] Veraguth A(1986)Hodgkin’s disease: Is there a price for successful treatment? A 25-year experience J Clin Oncol 12 153-66

[17] Lütolf M(1977)Longterm side effects in irradiated patients with Hodgkin’s disease Int J Radiat Oncol Biol Phys 2 1-19

[18] Hellbardt A(1992)Risk of second primary cancers after Hodgkins’s disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation Br Med I 304 1137-43

[19] Mirimanoff RO(1997)Second malignancy in patients with Hodgkin’s disease treated at the Royal Marsden Hospital Br J Can 75 116-23

[20] Obradovic M(1984)Second malignant neoplasms complicating Hodgkin’s disease: The National Cancer Institute experience J Clin Oncol 2 762-9